Efatutazone, an oral PPAR- γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: Results of a multicenter phase 1 trial

Robert C. Smallridge, J. A. Copland, M. S. Brose, J. T. Wadsworth, Y. Houvras, M. E. Menefee, K. C. Bible, M. H. Shah, A. W. Gramza, J. P. Klopper, L. A. Marlow, M. G. Heckman, R. Von Roemeling

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Efatutazone, an oral PPAR- γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: Results of a multicenter phase 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds